TREA

77504998 - NASALCARE

Follow

Information

  • Trademark
  • 77504998
  • Serial Number
    77504998
  • Registration Number
    3688173
  • Filing Date
    June 22, 2008
    17 years ago
  • Registration Date
    September 29, 2009
    16 years ago
  • Transaction Date
    February 11, 2020
    5 years ago
  • Status Date
    January 07, 2020
    5 years ago
  • Published for Opposition Date
    January 20, 2009
    16 years ago
  • Renewal Date
    September 29, 2019
    6 years ago
  • Location Date
    January 07, 2020
    5 years ago
  • First Use Anywhere Date
    January 02, 2007
    18 years ago
  • First Use In Commerce Date
    January 02, 2007
    18 years ago
Information
Mark Drawing Code
3000
Mark Identification
NASALCARE
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • D10000: "NASALCARE"
  • DM0000: The mark consists of the wording "NASALCARE" with two curved lines representing air or vapor emanating from the "L".
  • GS0051: [ Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; ] Antibacterial pharmaceuticals; [ Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; ] [ Antimicrobial preservatives for cosmetics and pharmaceuticals; ] [ Astringents; Bismuth preparations for pharmaceutical purposes; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; ] Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; [ Drug delivery agents in the form of a coating for macromolecule agents that facilitate the delivery of a wide range of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; ] Homeopathic pharmaceuticals for use in the treatment of allergy and respiratory tract infections; [ Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with anti-infectives and anti-allergy pharmaceuticals; ] [ Injectable pharmaceuticals for treatment of anaphylactic reactions; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; ] Pharmaceutical antitussive-cold preparations; [ Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; ] Pharmaceutical preparations and substances for the treatment of infectious diseases, [ blood disorders, ] pain, inflammation [, sepsis, alopecia, obesity and cognitive disorders ] ; [ Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; ] Pharmaceutical preparations for the prevention and treatment of [ ocular disorders or diseases, for the treatment of ] bacteria-based diseases, [ and for the treatment of diabetes, ] and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations [ and vaccines ] ; [ Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; ] Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; [ Pharmaceutical preparations for treating diabetes; ] Pharmaceutical preparations for use in chemotherapy; [ Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; ] Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; [ Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; ] Pharmaceuticals, namely, anti-infectives; [ Pharmaceuticals, namely, antihelmintics; ] [ Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and pharmaceutical purposes; ] [ Potassium preparations for pharmaceutical purposes; ] [ Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Synthetic peptides for pharmaceutical purposes; Unit dose capsules sold empty for pharmaceutical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes ]
  • PM0001: NASAL CARE
Case File Event Statements
  • 1/7/2020 - 5 years ago
    48 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Type: NA89
  • 1/7/2020 - 5 years ago
    47 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1
  • 1/7/2020 - 5 years ago
    46 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Type: 89AG
  • 1/6/2020 - 5 years ago
    45 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 1/3/2020 - 5 years ago
    44 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/7/2019 - 6 years ago
    43 - POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Type: PR89
  • 7/7/2019 - 6 years ago
    42 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 6/21/2019 - 6 years ago
    41 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/21/2019 - 6 years ago
    40 - TEAS SECTION 8 & 9 RECEIVED Type: E89R
  • 9/29/2018 - 7 years ago
    39 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2
  • 10/12/2016 - 9 years ago
    38 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 10/12/2016 - 9 years ago
    37 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A
  • 9/28/2016 - 9 years ago
    36 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 9/27/2016 - 9 years ago
    35 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 6/6/2016 - 9 years ago
    34 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/27/2016 - 9 years ago
    33 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/8/2016 - 9 years ago
    32 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/3/2016 - 9 years ago
    31 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/28/2016 - 9 years ago
    30 - POST REGISTRATION ACTION MAILED - SEC. 8 & 15 Type: PR23
  • 3/25/2016 - 9 years ago
    29 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/25/2016 - 9 years ago
    28 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 12/13/2014 - 10 years ago
    27 - POST REGISTRATION ACTION MAILED - SEC. 8 & 15 Type: PR23
  • 11/24/2014 - 10 years ago
    26 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 10/6/2014 - 11 years ago
    25 - POST REGISTRATION ACTION MAILED - SEC. 8 & 15 Type: PR23
  • 10/6/2014 - 11 years ago
    24 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 9/30/2014 - 11 years ago
    23 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 9/30/2014 - 11 years ago
    22 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/29/2009 - 16 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/26/2009 - 16 years ago
    20 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 8/26/2009 - 16 years ago
    19 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 8/26/2009 - 16 years ago
    18 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 3/12/2009 - 16 years ago
    17 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 2/4/2009 - 16 years ago
    16 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 1/20/2009 - 16 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/31/2008 - 16 years ago
    14 - NOTICE OF PUBLICATION Type: NPUB
  • 12/16/2008 - 16 years ago
    13 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 12/16/2008 - 16 years ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/16/2008 - 16 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/16/2008 - 16 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/16/2008 - 16 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 12/1/2008 - 16 years ago
    8 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/1/2008 - 16 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/3/2008 - 17 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/3/2008 - 17 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/3/2008 - 17 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/26/2008 - 17 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/26/2008 - 17 years ago
    2 - NOTICE OF DESIGN SEARCH CODE MAILED Type: MDSM
  • 6/25/2008 - 17 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP